You are here
International Agency for Research on Cancer (IARC)
The International Agency for Research on Cancer (IARC) is part of the World Health Organization. IARC's mission is to coordinate and conduct research on the causes of human cancer, the mechanisms of carcinogenesis, and to develop scientific strategies for cancer prevention and control. The Agency is involved in both epidemiological and laboratory research and disseminates scientific information through publications, meetings, courses, and fellowships.
IARC promotes international collaboration in cancer research. The Agency is inter-disciplinary, bringing together skills in epidemiology, laboratory sciences and biostatistics to identify the causes of cancer so that preventive measures may be adopted and the burden of disease and associated suffering reduced. A significant feature of the IARC is its expertise in coordinating research across countries and organizations; its independent role as an international organization facilitates this activity.
Role in the project
IARC will lead WP5 (Metabolomics, within SP3 - Internal exposome: omic approaches for developing novel biomarkers of exposure), WP10 (Impact and Dissemination), and will participate in WP7 (Other omics).
Key persons to be involved
Name | Expertise | Role in the project |
Professor Chris P. Wild | Cancer Scientist | WP10 |
Dr Augustin Scalbert | Analytical chemistry, food and nutrition research, application of metabolomics for biomarker discovery |
WP5, WP6, WP10 |
Dr Zdenko Herceg | Molecular biology, epigenetics and cancer research |
WP3 Leader |
Dr Sabina Rinaldi | Hormone analysis and cancer |
WP5, WP6 |
Dr Hector Hernandez Vargas | Epigenetics |
WP7 |
Mr David Achaintre | Metabolomics |
WP5 |
Mr Cyrille Cuenin | Epigenetics |
WP7 |
Ms Véronique Terrasse | Communication Specialist |
WP10 |